5. In the principal Regulations, in the Fourth Schedule —(a) | in paragraph 15, after item (8AB), insert — | 1-(3-Chlorophenyl)-2-(methylamino)propan-1-one (also known as 3‑chloromethcathinone or 3‑CMC)”; |
|
|
| (b) | in paragraph 17, after item (2A), insert — | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide (also known as ADB‑INACA or ADMB-INACA) and its N‑(1‑amino‑1‑oxohexan‑2‑yl) isomers”; |
|
|
| (c) | in paragraph 17, replace item (6H) with — | 1-(1-(1-(4-Bromophenyl)ethyl)-piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one (also known as Brorphine) and its bromo positional isomers in the phenyl ring”; |
|
|
| (d) | in paragraph 17, after item (19AA), insert — | N-Ethyl-1-(3-methoxyphenyl)-cyclohexanamine (also known as 3‑Methoxyeticyclidine or 3‑Methoxy‑PCE or 3‑MeO‑PCE) and its methoxy positional isomers in the phenyl ring |
| | 2-(Ethylamino)-2-(2-fluorophenyl)-cyclohexanone (also known as 2‑fluorodeschloro‑N‑ethyl‑ketamine, 2‑FDCNEK, 2‑fluoro‑2‑oxo PCE or 2‑fluoro NENDCK) and its fluoro positional isomers in the phenyl ring”; |
|
|
| (e) | in paragraph 17, renumber the existing item (19AB) relating to “4‑Fluoromethylphenidate and its fluoro positional isomers in the phenyl ring” as item (19B); | (f) | in paragraph 17, after item (27AA), insert — | 2-(1H-Indazole-3-carboxamido)-3,3‑dimethylbutanoic acid and its hexanoic acid isomers”; |
|
|
| (g) | in paragraph 18, after item (10), insert — | 5,6-Dimethoxy-N,N-diisopropyltryptamine (also known as 5,6‑Dimethoxy‑DiPT or 5,6‑MeO‑DiPT)”; |
|
|
| (h) | in paragraph 20, after item (10), insert — | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4,5-dihydroxypentyl)-1H-indazole-3-carboxamide”; |
|
|
| (i) | in paragraph 20, after item (13), insert — | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-hydroxycyclohexylmethyl)-1H-indazole-3-carboxamide |
| | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (also known as ADB-4en-PINACA, ADMB-4en-PINACA or ADB-PENINACA)”; and |
|
|
| (j) | in paragraph 20, after item (36B), insert — | Methyl 2-(1-butyl-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (also known as MDMB‑BUTINACA or MDMB-BINACA)”. |
|
|
|
|